Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for COVID-19
NCT04548557Phase 3Unknown
- Sponsor
- University of Health Sciences Lahore
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by University of Health Sciences Lahore. Primary endpoints: In hospital days and 14 day mortality. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04548557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04548557.